Author:
Dings Ruud P. M.,Chen Xuemei,Hellebrekers Debby M. E. I.,van Eijk Loes I.,Zhang Ying,Hoye Thomas R.,Griffioen Arjan W.,Mayo Kevin H.
Publisher
Oxford University Press (OUP)
Reference30 articles.
1. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev2000 ; 52 : 237 –68.
2. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell1997 ; 88 : 277 –85.
3. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature1997 ; 390 : 404 –7.
4. Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov2004 ; 3 : 391 –400.
5. Chen H, Herndon ME, Lawler J. The cell biology of thrombospondin-1. Matrix Biol2000 ; 19 : 597 –614.
Cited by
103 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献